Published in J Clin Endocrinol Metab on October 01, 1993
Insulin resistance in children with primary nephrotic syndrome and normal renal function. Pediatr Nephrol (2012) 2.03
Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A (1999) 1.91
Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter. Diabetologia (2007) 1.12
Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J Clin Invest (1998) 1.08
Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Cell Mol Life Sci (2006) 1.02
The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes (2012) 0.94
Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J (2002) 0.92
Obesity-related markers and breast cancer in CPS-II Nutrition Cohort. Int J Mol Epidemiol Genet (2013) 0.90
Does C-peptide have a physiological role? Diabetologia (1994) 0.88
A Molecular Level Understanding of Zinc Activation of C-peptide and its Effects on Cellular Communication in the Bloodstream. Rev Diabet Stud (2009) 0.82
Physiological effects and therapeutic potential of proinsulin C-peptide. Am J Physiol Endocrinol Metab (2014) 0.81
Relationship between modified homeostasis model assessment/correlative serum factors and diabetic retinopathy among type 2 diabetics with insulin therapy in Guangzhou, China. Int J Ophthalmol (2014) 0.81
C-Peptide: the missing link in diabetic nephropathy? Rev Diabet Stud (2009) 0.80
Serum C peptide level and renal function in diabetes mellitus. Indian J Nephrol (2010) 0.80
C-Peptide effects on renal physiology and diabetes. Exp Diabetes Res (2008) 0.80
The therapeutic potential of C-peptide in kidney disease: a protocol for a systematic review and meta-analysis. Syst Rev (2014) 0.77
Influence of C-peptide on glucose utilisation. Exp Diabetes Res (2008) 0.76
A microfluidic technique for monitoring bloodstream analytes indicative of C-peptide resistance in type 2 diabetes. Analyst (2008) 0.76
Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus. World J Diabetes (2015) 0.75
C-peptide as a Therapy for Kidney Disease: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.75
C-peptide has no effect on forearm blood flow during local hyperinsulinaemia in healthy humans. Br J Clin Pharmacol (2003) 0.75
Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet β-cells in recent-onset type 1 diabetes in NOD mice. Exp Ther Med (2016) 0.75
An update on the potential role of C-peptide in diabetes and osteoporosis. Endocrine (2017) 0.75
The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes (1981) 7.28
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest (1985) 4.38
Amino acid metabolism during prolonged starvation. J Clin Invest (1969) 4.06
Liver and kidney metabolism during prolonged starvation. J Clin Invest (1969) 3.47
Frequent use of the hospital emergency department is indicative of high use of other health care services. Ann Emerg Med (2001) 3.12
Leg blood flow during exercise in man. Clin Sci (1971) 2.97
Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes (1983) 2.45
Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids. J Clin Invest (1974) 2.40
Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest (1996) 2.33
Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man. J Clin Invest (1971) 2.29
Amino acid metabolism in exercising man. J Clin Invest (1971) 2.29
Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J Clin Invest (1976) 2.27
Glucose metabolism during leg exercise in man. J Clin Invest (1971) 2.27
Nonproductive exchanges: the use of isotopes gone astray. Metabolism (1992) 2.12
Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. J Clin Invest (1972) 2.11
Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci U S A (1978) 2.08
Increased 24-hour energy expenditure in cigarette smokers. N Engl J Med (1986) 2.01
Insulin resistance in uremia. J Clin Invest (1981) 1.98
Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res (1998) 1.92
Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A (1999) 1.91
The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes (1985) 1.88
Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state. J Clin Invest (1995) 1.76
Splanchnic glucose and amino acid metabolism in obesity. J Clin Invest (1974) 1.73
Fuel homeostasis in exercise. N Engl J Med (1975) 1.73
Influence of oral glucose ingestion on splanchnic glucose and gluconeogenic substrate metabolism in man. Diabetes (1975) 1.68
Uptake of individual free fatty acids by skeletal muscle and liver in man. J Clin Invest (1972) 1.63
Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet Med (2000) 1.63
Evidence of inter-organ amino-acid transport by blood cells in humans. Proc Natl Acad Sci U S A (1973) 1.60
Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest (1981) 1.59
Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes (1978) 1.58
Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J Clin Invest (1995) 1.58
Induction of Inorganic Carbon Accumulation in the Unicellular Green Algae Scenedesmus obliquus and Chlamydomonas reinhardtii. Plant Physiol (1988) 1.54
Simulation and evaluation of nicotine intake during passive smoking: cotinine measurements in body fluids of nonsmokers given intravenous infusions of nicotine. Clin Pharmacol Ther (1990) 1.52
The effect of local anaesthetics on the central circulation and respiration in man and dog. Acta Anaesthesiol Scand (1968) 1.50
Risk for fatal statin-induced rhabdomyolysis as a consequence of misinterpretation of 'evidence-based medicine'. J Intern Med (2005) 1.48
The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia (1992) 1.47
Infusion of ornithine-alpha-ketoglutarate in healthy subjects: effects on protein metabolism. Clin Nutr (1985) 1.47
Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus. J Clin Invest (1975) 1.46
Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab (1994) 1.44
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol (1983) 1.43
Noninvasive tracing of Krebs cycle metabolism in liver. J Biol Chem (1991) 1.43
Influence of age on the local circulatory adaptation to leg exercise. Scand J Clin Lab Invest (1974) 1.43
Hypoglycemia during prolonged exercise in normal men. N Engl J Med (1982) 1.42
Metabolism of [2-14C]acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis. J Biol Chem (1991) 1.38
Proinsulin C-peptide--a consensus statement. Int J Exp Diabetes Res (2001) 1.38
Beta-adrenergic blockade does not influence the thermogenic response to a mixed meal in man. Clin Physiol (1989) 1.38
Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin. Proc Natl Acad Sci U S A (1977) 1.35
Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet (1976) 1.33
Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol (1980) 1.32
Imaging in chronic achilles tendinopathy: a comparison of ultrasonography, magnetic resonance imaging and surgical findings in 27 histologically verified cases. Skeletal Radiol (1996) 1.30
Substance P: a pioneer amongst neuropeptides. J Intern Med (2001) 1.28
Human forearm muscle metabolism during exercise. II. Uptake, release and oxidation of individual FFA and glycerol. Scand J Clin Lab Invest (1968) 1.28
Substrate utilization by the inactive leg during one-leg or arm exercise. J Appl Physiol (1975) 1.23
Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes (1999) 1.22
Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia (1992) 1.22
Cerebral effects of nicotine during cognition in smokers and non-smokers. Psychopharmacology (Berl) (1998) 1.20
Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1987) 1.18
Determination of leg blood flow during exercise in man: an indicator-dilution technique based on femoral venous dye infusion. Clin Sci Mol Med (1973) 1.17
Quantitative aspects of blood flow and oxygen uptake in the human forearm during rhythmic exercise. Acta Physiol Scand Suppl (1966) 1.17
Augmented thermic effect of amino acids under general anaesthesia: a mechanism useful for prevention of anaesthesia-induced hypothermia. Clin Sci (Lond) (1994) 1.15
Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans. J Clin Invest (1977) 1.13
Circulatory responses to arm exercise with different arm positions. J Appl Physiol (1968) 1.13
Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus. Diabetes (1976) 1.13
Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise. J Clin Invest (1984) 1.12
Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men. Atherosclerosis (1997) 1.12
Renal substrate exchange in human diabetes mellitus. Diabetes (1975) 1.11
C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity in synergism with neuropeptide Y. Diabetologia (1996) 1.10
Physiological variation of blood lymphocyte reactivity: T-cell subsets, immunoglobulin production, and mixed-lymphocyte reactivity. Clin Immunol Immunopathol (1983) 1.10
Physical exercise and fuel homeostasis in diabetes mellitus. Diabetologia (1978) 1.09
Influence of beta-adrenergic blockade on glucose-induced thermogenesis in man. J Clin Invest (1983) 1.08
Human forearm muscle metabolism during exercise. V. Quantitative aspects of glucose uptake and lactate production during prolonged exercise. Scand J Clin Lab Invest (1970) 1.08
Plasma glucagon levels in exercising man. N Engl J Med (1972) 1.08
Leg glucose uptake during maximal dynamic exercise in humans. Am J Physiol (1986) 1.08
Influence of leucine on arterial concentrations and regional exchange of amino acids in healthy subjects. Clin Sci (Lond) (1980) 1.07
Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments. Diabetologia (1998) 1.07
C-peptide improves autonomic nerve function in IDDM patients. Diabetologia (1996) 1.06
Human forearm muscle metabolism during exercise. 3. Uptake, release and oxidation of beta-hydroxybutyrate and observations on the beta-hydroxybutyrate/acetoacetate ratio. Scand J Clin Lab Invest (1968) 1.06
Thermic effect of glucose in man. Obligatory and facultative thermogenesis. J Clin Invest (1984) 1.05
Quantifying gluconeogenesis during fasting. Am J Physiol (1997) 1.04
Muscle metabolism during exercise in hemiparetic patients. Clin Sci Mol Med (1977) 1.04
C-peptide stimulates Na+, K+-ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells. Cell Mol Life Sci (2004) 1.04
Protein turnover and amino acid metabolism in the regulation of gluconeogenesis. Fed Proc (1974) 1.04
Splanchnic glucose and muscle glycogen metabolism after glucose feeding during postexercise recovery. Am J Physiol (1978) 1.03
Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man. J Clin Invest (1976) 1.03
Long-term use of smokeless tobacco and physical performance in middle-aged men. Eur J Clin Invest (1997) 1.02
Glutamine and glutamate metabolism in normal and diabetic subjects. Diabetes (1973) 1.02
Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Cell Mol Life Sci (2006) 1.02
Effects of pancreas transplantation on metabolic and hormonal profiles in IDDM patients. Diabetes (1989) 1.02
The contrasting responses of splanchnic and renal glucose output to gluconeogenic substrates and to hypoglucagonemia in 60-h-fasted humans. Diabetes (1980) 1.02
Splanchnic and muscle metabolism during exercise in NIDDM patients. Am J Physiol (1995) 1.01
Renal oxygen consumption, thermogenesis, and amino acid utilization during i.v. infusion of amino acids in man. Am J Physiol (1994) 1.01
Human forearm muscle metabolism during exercise. VI. Substrate utilization in prolonged fasting. Scand J Clin Lab Invest (1971) 1.00
A limitation in the use of mass isotopomer distributions to measure gluconeogenesis in fasting humans. Am J Physiol (1995) 1.00
Glucose and amino acid metabolism during recovery after exercise. J Appl Physiol (1973) 1.00
Splanchnic and renal exchange of infused fructose in insulin-deficient type 1 diabetic patients and healthy controls. J Clin Invest (1989) 0.99